WisdomTree BioRevolution Fund (BATS:WDNA) Short Interest Update

WisdomTree BioRevolution Fund (BATS:WDNAGet Free Report) saw a significant increase in short interest in May. As of May 15th, there was short interest totaling 5,563 shares, an increase of 102.7% from the April 30th total of 2,744 shares. Approximately 3.7% of the shares of the company are short sold. Based on an average trading volume of 950 shares, the days-to-cover ratio is currently 5.9 days.

WisdomTree BioRevolution Fund Stock Performance

Shares of WDNA stock opened at $18.33 on Monday. The stock has a 50 day moving average of $17.70 and a 200 day moving average of $17.62. The stock has a market cap of $2.75 million, a P/E ratio of 17.03 and a beta of 1.01. WisdomTree BioRevolution Fund has a twelve month low of $12.28 and a twelve month high of $18.88.

Institutional Inflows and Outflows

An institutional investor recently raised its position in WisdomTree BioRevolution Fund stock. Flow Traders U.S. LLC boosted its stake in shares of WisdomTree BioRevolution Fund (BATS:WDNAFree Report) by 59.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 26,182 shares of the company’s stock after acquiring an additional 9,720 shares during the quarter. Flow Traders U.S. LLC owned 17.45% of WisdomTree BioRevolution Fund worth $416,000 at the end of the most recent reporting period.

WisdomTree BioRevolution Fund Company Profile

(Get Free Report)

The WisdomTree BioRevolution Fund (WDNA) is an exchange-traded fund that is based on the WisdomTree BioRevolution index. The fund tracks a modified equally-weighted index of companies in developed markets that focus on the advancements in genetics and biotechnology. WDNA was launched on Jun 3, 2021 and is managed by WisdomTree.

Featured Articles

Receive News & Ratings for WisdomTree BioRevolution Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WisdomTree BioRevolution Fund and related companies with MarketBeat.com's FREE daily email newsletter.